Orbimed Advisors LLC, a director at Electra Therapeutics, Inc., purchases $3.61M of stock
472,571 shares at about $7.63 each, bought on the open market between Nov 3 and Nov 5. Information only, not investment advice.
Orbimed Advisors LLC, a director of Electra Therapeutics, Inc. (ETRA), bought 472,571 shares between Nov 3 and Nov 5 at an average price of $7.63, a total of $3.61 million, according to a Form 4 filed with the SEC on Nov 5.
The filing reports the shares as held indirectly, for example through a trust or a fund. The trade was reported within two business days, as Section 16 requires.
After the trade, the filing lists 7,357,741 shares held.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Electra Therapeutics, Inc. (ETRA) |
|---|---|
| Insider | Orbimed Advisors LLC |
| Role | Director |
| Transaction | Open-market purchase (code P) |
| Shares | 472,571 |
| Average price | $7.63 |
| Value | $3,605,117 |
| Trade dates | Nov 3 to Nov 5, 2026 |
| Filed with the SEC | Nov 5, 2026, 5:39 PM ET |
| Shares held after | 7,357,741 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
See every transaction in this Electra Therapeutics, Inc. filing
Browse the insider trading newsroom · See the biggest insider trades of each day
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
Related Articles
- Insider Trading News
Carl L. Gordon, a director at Electra Therapeutics, Inc., buys $3.61M of stock
- Insider Trading News
Orbimed Advisors LLC, a director at Aspen Neuroscience, Inc., purchases $15M of stock
- Insider Trading News
Insider buying and selling on Nov 4: Orbimed Advisors LLC leads with $15M
- Insider Trading News
RA Capital Management, L.P., a director at Bambusa Therapeutics, Inc., buys $46.6M of stock
- Insider Trading News
10% owner Venrock Healthcare Capital Partners III, L.P. buys $223,820 of Lycia Therapeutics, Inc. stock
